These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21130708)

  • 1. Improved strut coverage and less late incomplete apposition with thin-strut TAXUS Liberté vs. TAXUS Express: the importance of stent platform design for drug-eluting stents.
    Weissman NJ; Turco MA; Ormiston JA; Mann T; Cannon LA; McGarry TF; Webster MW; Hall JJ; Lucca MJ; Mishkel GJ; Wu CJ; Mandinov L; Dawkins KD
    Cardiovasc Revasc Med; 2011; 12(4):247-57. PubMed ID: 21130708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberté stent: 1-year results from the TAXUS ATLAS program.
    Turco MA; Ormiston JA; Popma JJ; Hall JJ; Mann T; Cannon LA; Webster MW; Mishkel GJ; O'Shaughnessy CD; McGarry TF; Mandinov L; Dawkins KD; Baim DS
    JACC Cardiovasc Interv; 2008 Dec; 1(6):699-709. PubMed ID: 19463387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term impact of routinely detected early and late incomplete stent apposition: an integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent studies.
    Steinberg DH; Mintz GS; Mandinov L; Yu A; Ellis SG; Grube E; Dawkins KD; Ormiston J; Turco MA; Stone GW; Weissman NJ
    JACC Cardiovasc Interv; 2010 May; 3(5):486-94. PubMed ID: 20488404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2.
    Chevalier B; Silber S; Park SJ; Garcia E; Schuler G; Suryapranata H; Koolen J; Hauptmann KE; Wijns W; Morice MC; Carrie D; van Es GA; Nagai H; Detiege D; Paunovic D; Serruys PW;
    Circ Cardiovasc Interv; 2009 Jun; 2(3):188-95. PubMed ID: 20031715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the polymer-based, paclitaxel-eluting TAXUS Express stent on vascular tissue responses: a volumetric intravascular ultrasound integrated analysis from the TAXUS IV, V, and VI trials.
    Weissman NJ; Ellis SG; Grube E; Dawkins KD; Greenberg JD; Mann T; Cannon LA; Cambier PA; Fernandez S; Mintz GS; Mandinov L; Koglin J; Stone GW
    Eur Heart J; 2007 Jul; 28(13):1574-82. PubMed ID: 17540849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial.
    Weissman NJ; Koglin J; Cox DA; Hermiller J; O'Shaughnessy C; Mann JT; Turco M; Caputo R; Bergin P; Greenberg J; Kutcher M; Wong SC; Strickland W; Mooney M; Russell ME; Ellis SG; Stone GW
    J Am Coll Cardiol; 2005 Apr; 45(8):1201-5. PubMed ID: 15837249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic arterial responses to overlapping paclitaxel-eluting stents: insights from serial intravascular ultrasound analyses in the TAXUS-V and -VI trials.
    Aoki J; Mintz GS; Weissman NJ; Mann JT; Cannon L; Greenberg J; Grube E; Masud AR; Koglin J; Mandinov L; Stone GW
    JACC Cardiovasc Interv; 2008 Apr; 1(2):161-7. PubMed ID: 19463294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravascular ultrasound insights from the Cobalt Chromium Stent With Antiproliferative for Restenosis II (COSTAR II) trial comparing CoStar and Taxus paclitaxel-eluting stents.
    Tsujino I; Koizumi T; Shimohama T; Ako J; Waseda K; Krucoff M; Honda Y; Fitzgerald PJ
    Cardiovasc Revasc Med; 2012; 13(2):111-8. PubMed ID: 22406056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial intravascular ultrasound analysis of stent strut distribution and fracture: an integrated analysis of the taxus IV, V, and VI trials.
    Pracon R; Opolski MP; Mintz GS; Pregowski J; Kruk M; Popma JJ; Mandinov L; Wang H; Ellis SG; Grube E; Dawkins KD; Stone GW; Weissman NJ
    J Invasive Cardiol; 2014 Oct; 26(10):501-11. PubMed ID: 25274860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Final 5-year results of the TAXUS ATLAS, TAXUS ATLAS Small Vessel, and TAXUS ATLAS Long Lesion clinical trials of the TAXUS Liberté paclitaxel-eluting stent in de-novo coronary artery lesions.
    Ormiston JA; Charles O; Mann T; Hall JJ; McGarry T; Cannon LA; Webster MW; Mishkel GJ; Underwood PL; Dawkins KD
    Coron Artery Dis; 2013 Jan; 24(1):61-8. PubMed ID: 23232250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravascular ultrasound results from the NEVO ResElution-I trial: a randomized, blinded comparison of sirolimus-eluting NEVO stents with paclitaxel-eluting TAXUS Liberté stents in de novo native coronary artery lesions.
    Otake H; Honda Y; Courtney BK; Shimohama T; Ako J; Waseda K; Macours N; Rogers C; Popma JJ; Abizaid A; Ormiston JA; Spaulding C; Cohen SA; Fitzgerald PJ
    Circ Cardiovasc Interv; 2011 Apr; 4(2):146-54. PubMed ID: 21386089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of the TAXUS Liberté SR paclitaxel-eluting coronary stent.
    Ahmed WH
    Expert Rev Med Devices; 2007 Mar; 4(2):117-20. PubMed ID: 17359218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propensity-matched patient-level comparison of the TAXUS Liberté and TAXUS element (ION) paclitaxel-eluting stents.
    Kereiakes DJ; Cannon LA; Ormiston JA; Turco MA; Mann T; Mishkel GJ; McGarry T; Wang H; Underwood P; Dawkins KD
    Am J Cardiol; 2011 Sep; 108(6):828-37. PubMed ID: 21803319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: the Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial.
    Jensen LO; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Galloe A; Kelbaek H; Lassen JF; Thuesen L
    Eur Heart J; 2008 Nov; 29(22):2733-41. PubMed ID: 18832385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct stenting with the TAXUS Liberté drug-eluting stent: results from the Taxus Atlas Direct Stent Study.
    Ormiston JA; Mahmud E; Turco MA; Popma JJ; Weissman N; Cannon LA; Mann T; Lucca MJ; Lim ST; Hall JJ; McClean D; Dobies D; Mandinov L; Baim DS
    JACC Cardiovasc Interv; 2008 Apr; 1(2):150-60. PubMed ID: 19463293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes between different stent designs with the same polymer and drug: comparison between the Taxus Express and Taxus Liberte stents.
    Son JW; Kim U; Park JS; Kim YJ; Jang JS; Yang TH; Kim DS; Kim DK; Seol SH; Kim DI; Nam CW; Hur SH; Kim KB
    Korean J Intern Med; 2013 Jan; 28(1):72-80. PubMed ID: 23345999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strut coverage and vessel wall response to a new-generation paclitaxel-eluting stent with an ultrathin biodegradable abluminal polymer: Optical Coherence Tomography Drug-Eluting Stent Investigation (OCTDESI).
    Guagliumi G; Sirbu V; Musumeci G; Bezerra HG; Aprile A; Kyono H; Fiocca L; Matiashvili A; Lortkipanidze N; Vassileva A; Popma JJ; Allocco DJ; Dawkins KD; Valsecchi O; Costa MA
    Circ Cardiovasc Interv; 2010 Aug; 3(4):367-75. PubMed ID: 20647562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.
    Waseda K; Miyazawa A; Ako J; Hasegawa T; Tsujino I; Sakurai R; Yock PG; Honda Y; Kandzari DE; Leon MB; Fitzgerald PJ;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):779-84. PubMed ID: 19695548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.